Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 27

Sort by

Sort Order Select

Journal Articles

Impact of T-Cell Dose on Gvhd Risk after Allogeneic HLA-Matched PBSC Transplantation

Ayman Saad, MD, Tao Wang, PhD, Michael T. Hemmer, MS, Stephen R. Spellman, Mukta Arora, MD, Lawrence S. Lamb, Jr., PhD, Shahrukh K. Hashmi, MD MPH

Blood (2018) 132 (Supplement 1): 3410.

https://doi.org/10.1182/blood-2018-99-113513

Published: 2018

Journal Articles

A Phase II of Combination Daunorubicin and Cytarabine (Ara-C) and Nilotinib (TASIGNA) (DATA) in Patients Newly Diagnosed with Acute Myeloid Leukemia and KIT Expression: Final Results

Aref Al-Kali, MD, Raoul Tibes, MD PhD, Jeanne Palmer, MD, Hassan B. Alkhateeb, MD, Mrinal M. Patnaik, MD MBBS, Kebede H. Begna, MD, Naseema Gangat, MBBS, Pamela Atherton, Shujun Liu, PhD, Rong He, MD, Shahrukh K. Hashmi, MD MPH, Mark R. Litzow, MD

Blood (2018) 132 (Supplement 1): 1443.

https://doi.org/10.1182/blood-2018-99-118552

Published: 2018

Journal Articles

Trends in Multiple Myeloma Incidence in the United States (US): Demographic and Geographic Considerations and Focus on Young Adults

Gordon Ruan, MD, Gaurav Goyal, MBBS, Shahrukh K. Hashmi, MD MPH, Prashant Kapoor, MD, Ronald S. Go, MD

Blood (2018) 132 (Supplement 1): 5575.

https://doi.org/10.1182/blood-2018-99-114105

Published: 2018

Journal Articles

The Impact of Marital Status on Hematopoietic Stem Cell Transplant (HCT) Recipient Outcomes: A Surrogate for Consistent Caregiver. a CIBMTR Registry Study

Jason Tay, MD, Ruta Brazauskas, PhD, Naya He, Sara Beattie, Christopher Bredeson, MD FRCPC, MSc, Jignesh Dalal, MD, Shahrukh K. Hashmi, MD MPH, Theresa E. Hahn, PhD, Nandita Khera, MD, William A. Wood, MD MPH, Wael Saber, MD MS

Blood (2018) 132 (Supplement 1): 4788.

https://doi.org/10.1182/blood-2018-99-117027

Published: 2018

Journal Articles

Lost to Follow-up Rates Are Higher in Pediatric Than Adult Survivors, but Not By Transplant Type: A Report from the Center for International Blood and Marrow Transplant Research

David K. Buchbinder, MD MSHS, Ruta Brazauskas, PhD, Khalid Bo-Subait, Karen K. Ballen, MD, Theresa E. Hahn, PhD, Tami D John, MD, Susan K Parsons, MD MRP, Shahrukh K. Hashmi, MD MPH, Nandita Khera, MD, William A. Wood, MD MPH, Wael Saber, MD MS

Blood (2018) 132 (Supplement 1): 2260.

https://doi.org/10.1182/blood-2018-99-116531

Published: 2018

Journal Articles

Histopathologic Acute Lung Injury after Allogeneic Hematopoietic Cell Transplantation: Clinical Findings, Radiologic Features, Treatments and Outcomes

Mehrdad Hefazi, MD, Shahrukh K. Hashmi, MD MPH, Anja C. Roden, MD, Mrinal M. Patnaik, MD MBBS, Reona Sakemura, MD PhD, Nandita Khera, MD, Vivek Roy, MD, Cassie C. Kennedy, MD, William J. Hogan, MB, BCh, Mark R. Litzow, MD, Hemang Yadav, MBBS

Blood (2018) 132 (Supplement 1): 2113.

https://doi.org/10.1182/blood-2018-99-118930

Published: 2018

Journal Articles

Sex-Based Disparities in Venous Thromboembolism Sociodemographics and Outcomes: A National Inpatient Sample (NIS)-Based Analysis

Ariela L. Marshall, MD, Adam C Bartley, MS, Aneel A. Ashrani, MD MS, Wilson I Gonsalves, MD, Prashant Kapoor, MD, Shahrukh K. Hashmi, MD, Mustaqeem A. Siddiqui, MD, Urshila Durani, MD MPH, Ronald S. Go, MD

Blood (2016) 128 (22): 5918.

https://doi.org/10.1182/blood.V128.22.5918.5918

Published: 2016

Journal Articles

Racial Disparity in Drug Utilization Among Multiple Myeloma Patients: A SEER Medicare Analysis

Sikander Ailawadhi, MD, Ryan D Frank, MS, Richa Menghani, MD, Mayank Sharma, MBBS, M'hamed Temkit, Shumail M. Paulus, MBBS, Nandita Khera, MD, Shahrukh K. Hashmi, MD, Pooja Advani, MBBS, Abhisek Swaika, MBBS, Aneel Paulus, MD MS, Vivek Roy, MD, Gerardo Colon-Otero, MD, Asher A. Chanan-Khan, MD

Blood (2016) 128 (22): 3542.

https://doi.org/10.1182/blood.V128.22.3542.3542

Published: 2016

Journal Articles

Disparities in the Upfront Use of Hematopoietic Stem Cell Transplant Among Patients with Acute Myeloid Leukemia

Tahir Mehmood, MD, Adam C Bartley, MS, Shahrukh K. Hashmi, MD, Ronald S. Go, MD

Blood (2016) 128 (22): 3543.

https://doi.org/10.1182/blood.V128.22.3543.3543

Published: 2016

Journal Articles

Trends in Disease Presentation, Management, Cost of Care and Outcomes: A Comprehensive Look at Racial Disparities in Multiple Myeloma (MM)

Sikander Ailawadhi, MD, Ryan D Frank, MS, Mayank Sharma, MBBS, Richa Menghani, MD, M'hamed Temkit, Shumail M. Paulus, MBBS, Nandita Khera, MD, Shahrukh K. Hashmi, MD, Pooja Advani, MBBS, Abhisek Swaika, MBBS, Aneel Paulus, MD, Nabeel Aslam, MD, Vivek Roy, MD, Gerardo Colon-Otero, MD, Asher A. Chanan-Khan, MD

Blood (2016) 128 (22): 3544.

https://doi.org/10.1182/blood.V128.22.3544.3544

Published: 2016

Journal Articles

Phase I/IB Study of Azacitidine and Hedgehog Pathway Inhibition in Myeloid Malignancies

Raoul Tibes, MD PhD, Heidi E. Kosiorek, MS, Amylou C. Dueck, PhD, Lisa Sproat, MD MSW, Jeanne Palmer, MD, James L. Slack, MD, Devinder Singh, MD, Eileen Gebhart, MSN, RN, ANP-BC, Emily Knight, RN, Shahrukh K. Hashmi, MD, Ryan A Wilcox, MD PhD, James M Bogenberger, PhD, Ruben A. Mesa, Aref Al-Kali, MD

Blood (2015) 126 (23): 1347.

https://doi.org/10.1182/blood.V126.23.1347.1347

Published: 2015

Journal Articles

Clofarabine Based Chemotherapy in Adult Relapsed/Refractory Acute Lymphoblastic Leukemia/Lymphoma-a Single Institution Experience

Hassan B Alkhateeb, MD, Moussab Damlaj, MD, Tasha Lin, MD, Aref Al-Kali, MD, Lisa Sproat, MD MSW, Jeffrey Alan Betcher, BSPharm, RPh, Jason N. Barreto, PharmD, Shahrukh K. Hashmi, MD, Mrinal M Patnaik, MBBS, Naseema Gangat, MBBS, Michelle Elliott, MD, Mark R Litzow, MD, William J Hogan, MBChB

Blood (2015) 126 (23): 4910.

https://doi.org/10.1182/blood.V126.23.4910.4910

Published: 2015

Journal Articles

Clinical Outcome of Hypomethylating Agents in Hypocellular MDS: Mayo Clinic Experience

Sonia Cerquozzi, MD, Hassan B Alkhateeb, MD, Moritz Binder, MD MPH, Darci Zblewski, CNP, Shahrukh K Hashmi, MD, Mrinal M Patnaik, MBBS, William J. Hogan, MBChB, Mark R. Litzow, MD, Aref Al-Kali, MD

Blood (2015) 126 (23): 5254.

https://doi.org/10.1182/blood.V126.23.5254.5254

Published: 2015

Journal Articles

A Phase II of Combination D aunorubicin and Cytarabine ( A ra-c) and Nilotinib ( TA signa) (DATA) in Patients Newly Diagnosed with Acute Myeloid Leukemia and KIT Expression: Interim Results

Aref Al-Kali, MD, Raoul Tibes, MD PhD, Jeanne Palmer, MD, Hassan B Alkhateeb, MD, Pamela Atherton, Fei Yan, Shujun Liu, PhD, Rong He, MD, Shahrukh K. Hashmi, MD, Mark R Litzow, MD

Blood (2015) 126 (23): 3808.

https://doi.org/10.1182/blood.V126.23.3808.3808

Published: 2015

Journal Articles

Estimating the Annual Volume of Hematologic Cancer Cases per Hematologist-Oncologist in the United States: Are We Treating Rare Cancers Too Rarely?

Aishwarya Ravindran, MBBS, Wilson I. Gonsalves, MD, Shahrukh K. Hashmi, MD, Prashant Kapoor, MD, Ariela L. Marshall, MD, Mustaqeem A. Siddiqui, MD, Ronald S. Go, MD

Blood (2015) 126 (23): 3297.

https://doi.org/10.1182/blood.V126.23.3297.3297

Published: 2015

Journal Articles

Prognostic Impact of Peripheral Blood Count Recovery and Cytogenetic Remission Prior to Reduced Intensity Allogeneic Transplantation in Patients with Acute Myelogenous Leukemia and Myelodysplastic Syndromes

Moussab Damlaj, MD, Hassan B Alkhateeb, MD, Mehrdad Hefazi, MD, Daniel K. Partain, MD, Aref Al-Kali, MD, Shahrukh K. Hashmi, MD, Naseema Gangat, MBBS, Mark R Litzow, MD, William J Hogan, MBChB, Mrinal M Patnaik, MBBS

Blood (2015) 126 (23): 3210.

https://doi.org/10.1182/blood.V126.23.3210.3210

Published: 2015

Journal Articles

Fludarabine Busulfan Compared to Fludarabine Melphalan Is Associated with Increased Relapse Risk in Reduced Intensity Conditioning Transplant Despite Pharmacokinetic Dosing

Moussab Damlaj, MD, Hassan B Alkhateeb, MD, Daniel K. Partain, MD, Jehad Almasri, MD, Mehrdad Hefazi, MD, Shahrukh K. Hashmi, MD, Dennis A. Gastineau, MD, Aref Al-Kali, MD, Robert C Wolf, PharmD, Naseema Gangat, MBBS, Mark R Litzow, MD, William J Hogan, MBChB, Mrinal M Patnaik, MBBS

Blood (2015) 126 (23): 736.

https://doi.org/10.1182/blood.V126.23.736.736

Published: 2015

Journal Articles

The Role of Spleen Directed Therapy and Predictors of Outcomes with Reduced Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Primary Myelofibrosis and Splenomegaly

Daniel K. Partain, MD, Moussab Damlaj, MD, Aref Al-Kali, MD, Naseema Gangat, MBBS, Mark R Litzow, MD, William J Hogan, MBChB, Shahrukh K. Hashmi, MD, Wilson I. Gonsalves, MD, James M. Foran, MD, Vivek Roy, MD FACP, Ruben A. Mesa, Jeanne Palmer, MD, James L. Slack, MD, Mrinal M Patnaik, MBBS

Blood (2015) 126 (23): 4370.

https://doi.org/10.1182/blood.V126.23.4370.4370

Published: 2015

Journal Articles

Early CMV Infection Detected By Quantitative Nucleic Acid Testing (QNAT) Is Associated with Lower Risk of Relapse after Reduced Intensity, but Not Myeloablative, Hematopoietic Cell Transplantation in Acute Myeloid Leukemia

Mehrdad Hefazi Torghabeh, MD, Moussab Damlaj, MD, Hassan B Alkhateeb, MD, Raymund Razonable, MD, Aref Al-Kali, MD, Shahrukh K. Hashmi, MD, William J Hogan, MD, Mark R Litzow, MD, Mrinal M Patnaik, MBBS

Blood (2015) 126 (23): 1913.

https://doi.org/10.1182/blood.V126.23.1913.1913

Published: 2015

Journal Articles

Early T-Lymphocyte Chimerism Kinetics Is Influenced By Conditioning Regimen in Reduced Intensity Allogeneic Stem Cell Transplantation

Nosha Farhadfar, MD, Damlaj Moussab, MD, Ajoy L. Dias, MD, Hassan B Alkhateeb, MD, Mark R Litzow, MD, Shahrukh K. Hashmi, MD, Mrinal M Patnaik, MBBS, William J Hogan, MBChB

Blood (2015) 126 (23): 1923.

https://doi.org/10.1182/blood.V126.23.1923.1923

Published: 2015

NARROW

Impact of T-Cell Dose on Gvhd Risk after Allogeneic HLA-Matched PBSC Transplantation

A Phase II of Combination Daunorubicin and Cytarabine (Ara-C) and Nilotinib (TASIGNA) (DATA) in Patients Newly Diagnosed with Acute Myeloid Leukemia and KIT Expression: Final Results

Trends in Multiple Myeloma Incidence in the United States (US): Demographic and Geographic Considerations and Focus on Young Adults

The Impact of Marital Status on Hematopoietic Stem Cell Transplant (HCT) Recipient Outcomes: A Surrogate for Consistent Caregiver. a CIBMTR Registry Study

Lost to Follow-up Rates Are Higher in Pediatric Than Adult Survivors, but Not By Transplant Type: A Report from the Center for International Blood and Marrow Transplant Research

Histopathologic Acute Lung Injury after Allogeneic Hematopoietic Cell Transplantation: Clinical Findings, Radiologic Features, Treatments and Outcomes

Sex-Based Disparities in Venous Thromboembolism Sociodemographics and Outcomes: A National Inpatient Sample (NIS)-Based Analysis

Racial Disparity in Drug Utilization Among Multiple Myeloma Patients: A SEER Medicare Analysis

Disparities in the Upfront Use of Hematopoietic Stem Cell Transplant Among Patients with Acute Myeloid Leukemia

Trends in Disease Presentation, Management, Cost of Care and Outcomes: A Comprehensive Look at Racial Disparities in Multiple Myeloma (MM)

Phase I/IB Study of Azacitidine and Hedgehog Pathway Inhibition in Myeloid Malignancies

Clofarabine Based Chemotherapy in Adult Relapsed/Refractory Acute Lymphoblastic Leukemia/Lymphoma-a Single Institution Experience

Clinical Outcome of Hypomethylating Agents in Hypocellular MDS: Mayo Clinic Experience

A Phase II of Combination D aunorubicin and Cytarabine ( A ra-c) and Nilotinib ( TA signa) (DATA) in Patients Newly Diagnosed with Acute Myeloid Leukemia and KIT Expression: Interim Results

Estimating the Annual Volume of Hematologic Cancer Cases per Hematologist-Oncologist in the United States: Are We Treating Rare Cancers Too Rarely?

Prognostic Impact of Peripheral Blood Count Recovery and Cytogenetic Remission Prior to Reduced Intensity Allogeneic Transplantation in Patients with Acute Myelogenous Leukemia and Myelodysplastic Syndromes

Fludarabine Busulfan Compared to Fludarabine Melphalan Is Associated with Increased Relapse Risk in Reduced Intensity Conditioning Transplant Despite Pharmacokinetic Dosing

The Role of Spleen Directed Therapy and Predictors of Outcomes with Reduced Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Primary Myelofibrosis and Splenomegaly

Early CMV Infection Detected By Quantitative Nucleic Acid Testing (QNAT) Is Associated with Lower Risk of Relapse after Reduced Intensity, but Not Myeloablative, Hematopoietic Cell Transplantation in Acute Myeloid Leukemia

Early T-Lymphocyte Chimerism Kinetics Is Influenced By Conditioning Regimen in Reduced Intensity Allogeneic Stem Cell Transplantation

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only